Niki BioSolutions, Inc. Common Stock

NIKINASDAQ • USD
2.21 USD
↘ 0.01 (0.45%)🟢LIVE (AS OF 02:12 PM EDT)
🟢Market: OPEN

Shares of Niki BioSolutions, Inc. Common Stock (NIKI) are trading at $2.21. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Oct 15, 2026.

Open?$2.32
High?$2.62
Low?$1.83
Prev. Close?$2.22
Volume?20.2K
Avg. Volume?N/A
VWAP?$2.26
Bid / Ask
Bid?$1.79 × 100
Ask?$2.68 × 100
Spread?$0.89
Midpoint?$2.24
Valuation & Ratios
Market Cap?1.8M
Shares Out?N/A
Float?4.8M
Float %?76.0%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Its project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA).
Employees
2
Market Cap
1.8M
Industry
N/A
Listed
2018-12-18
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.30%Low
Short Interest?14.6K
Days to Cover?1.0
Free Float4.8M
Avg Daily Volume46.8K
Settlement Date2026-09-30